05/13/2024
🔬 Unlocking Insights with GT Molecular’s Cancer Research Panels for the Bio-Rad QX200™/QX600™ ddPCR™ Platforms
GT Molecular has developed high-sensitivity PCR panels designed specifically for cancer research, providing valuable results for actionable mutations.
🌟 GT Molecular’s Patent-Pending Digital PCR Kits 🌟
◾ EGFR Panel targets over 30 actionable mutations in the EGFR gene!
◾ KRAS G12C;G12 Kit for the detection of KRAS G12C associated with non-small cell lung cancers (NSCLC).
◾ NPM1-W288FS*12 Insertion Kit (Beta) for the detection of NPM1-W288fs*12 mutations found in Acute Myeloid Leukemia.
🔍 Why Choose GT Molecular?
◾ High sensitivity (at least 0.01% VAF; 3-4 copies per reaction for all targets).
◾ Wet lab tested and validated with all necessary controls
◾ Economical and rapid results, even on the same day
◾ Compatible with FFPE and liquid biopsy sample types
📩 Interested? We have many more assay on a variatey of platforms. Visit our website: http://gtmolecular.com or contact us directly for inquiries.
🚀🧬
Bio-Rad Laboratories Bio-Rad Genomics
American Association for Cancer Research (AACR)